Rani Therapeutics Holdings Inc. (RANI)
Market is closed
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
- 1 - 5
- Next >>
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 8,500,000 | $11,475,000 | 1.18% | |
| 2. | RA Capital Management Peter Kolchinsky | 8,500,000 | $11,475,000 | 0.12% | |
| 3. | Longaeva Partners Peter Goodwin | 2,113,435 | $2,853,137 | 0.24% | |
| 4. | Siren L.L.C. Raymond Debbane | 2,000,000 | $2,700,000 | 0.08% | |
| 5. | 683 Capital Partners Ari Zweiman | 487,168 | $657,677 | 0.03% |
Hedge Fund Resource Center